DUI Evaluation and Treatment Servs

DUI Evaluation and Treatment Servs is a SAMHSA-registered addiction-treatment facility in Springfield, IL. The facility's programming is outpatient (Outpatient), not residential. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at DUI Evaluation and Treatment Servs

On care levels: DUI Evaluation and Treatment Servs is an outpatient-focused program (Outpatient) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The critical pre-admission step is an independent clinical assessment that establishes ASAM 4e level-of-care recommendation. Admission at a facility whose offered level does not match the clinical assessment produces most misaligned-placement outcomes.

Insurance and payment

Payment and insurance specifics for DUI Evaluation and Treatment Servs are not fully documented in the SAMHSA registry — a direct admissions conversation is the reliable way to confirm what forms of payment are accepted and at what network-contract level. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Before you call

Three pre-admission questions for DUI Evaluation and Treatment Servs: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether DUI Evaluation and Treatment Servs offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.